# BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction

> **NCT02876042** · — · UNKNOWN · sponsor: **CVRx, Inc.** · enrollment: 70 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** BAROSTIM NEO™ System

## Key facts

- **NCT ID:** NCT02876042
- **Lead sponsor:** CVRx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-23
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02876042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02876042, "BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02876042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*